Conferences

Source: OncLive, July 2019 Five years out, one-third of patients with unresectable or metastatic BRAF V600-mutant melanoma remained alive following treatment with dual targeted therapy with dabrafenib (Tafinlar) plus trametinib (Mekinist), and…

Source: ECancer News, July 2019 Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma at Roswell Park Comprehensive Cancer Center, led research on the…

Source: ECancer News, July 2019 Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma at Roswell Park Comprehensive Cancer Center, led research on the…

Source: Medscape Pharmacist, January 2019 An extensive analysis of a World Health Organization (WHO) global database has identified myocarditis, pericardial diseases, cardiac arrhythmias, and vasculitis as significant immune-related cardiac toxicities associated with the…